Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in: Respiratory Research 1/2010

Open Access 01-12-2010 | Research

Ovalbumin sensitization and challenge increases the number of lung cells possessing a mesenchymal stromal cell phenotype

Authors: J Kelley Bentley, Antonia P Popova, Paul D Bozyk, Marisa J Linn, Amy E Baek, Jing Lei, Adam M Goldsmith, Marc B Hershenson

Published in: Respiratory Research | Issue 1/2010

Login to get access

Abstract

Background

Recent studies have indicated the presence of multipotent mesenchymal stromal cells (MSCs) in human lung diseases. Excess airway smooth muscle, myofibroblasts and activated fibroblasts have each been noted in asthma, suggesting that mesenchymal progenitor cells play a role in asthma pathogenesis. We therefore sought to determine whether MSCs are present in the lungs of ovalbumin (OVA)-sensitized and challenged mice, a model of allergic airways disease.

Methods

Balb/c mice were sensitized and challenged with PBS or OVA over a 25 day period. Flow cytometry as well as colony forming and differentiation potential were used to analyze the emergence of MSCs along with gene expression studies using immunochemical analyses, quantitative polymerase chain reaction (qPCR), and gene expression beadchips.

Results

A CD45-negative subset of cells expressed Stro-1, Sca-1, CD73 and CD105. Selection for these markers and negative selection against CD45 yielded a population of cells capable of adipogenic, osteogenic and chondrogenic differentiation. Lungs from OVA-treated mice demonstrated a greater average colony forming unit-fibroblast (CFU-F) than control mice. Sorted cells differed from unsorted lung adherent cells, exhibiting a pattern of gene expression nearly identical to bone marrow-derived sorted cells. Finally, cells isolated from the bronchoalveolar lavage of a human asthma patient showed identical patterns of cell surface markers and differentiation potential.

Conclusions

In summary, allergen sensitization and challenge is accompanied by an increase of MSCs resident in the lungs that may regulate inflammatory and fibrotic responses.
Appendix
Available only for authorised users
Literature
1.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak D: Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science 1999, 284:143–147.CrossRefPubMed
2.
Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, Maini RN: Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000, 2:477–488.CrossRefPubMedPubMedCentral
3.
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH: Human Adipose Tissue Is a Source of Multipotent Stem Cells. Mol Biol Cell 2002, 13:4279–4295.CrossRefPubMedPubMedCentral
4.
De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP: Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001, 44:1928–1942.CrossRefPubMed
5.
Tuli R, Tuli S, Nandi S, Wang ML, Alexander PG, Haleem-Smith H, Hozack WJ, Manner PA, Danielson KG, Tuan RS: Characterization of Multipotential Mesenchymal Progenitor Cells Derived from Human Trabecular Bone. Stem Cells 2003, 21:681–693.CrossRefPubMed
6.
Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, et al.: A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs. Cell Stem Cell 2008,3(3):301–313.CrossRefPubMed
7.
Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, Gronthos S: Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 2008, 214:413–421.CrossRefPubMed
8.
Tare RS, Babister JC, Kanczler J, Oreffo RO: Skeletal stem cells: Phenotype, biology and environmental niches informing tissue regeneration. Mol Cell Endocrinol 2008, 288:11–21.CrossRefPubMed
9.
da Silva Meirelles L, Chagastelles PC, Nardi NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006, 119:2204–2213.CrossRefPubMed
10.
Sabatini F, Petecchia L, Tavian M, Jodon de Villeroche V, Rossi GA, Brouty-Boye D: Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest 2005, 85:962–971.CrossRefPubMed
11.
Hennrick KT, Keeton AG, Nanua S, Kijek TG, Goldsmith AM, Sajjan US, Bentley JK, Lama VN, Moore BB, Schumacher RE, et al.: Lung cells from neonates show a mesenchymal stem cell phenotype. Am J Respir Crit Care Med 2007, 175:1158–1164.CrossRefPubMed
12.
Lama VN, Smith L, Badri L, Flint AJ, Andrei AC, Murray S, Wang Z, Liao H, Toews GB, Krebsbach PH, et al.: Evidence for Tissue-Resident Mesenchymal Stem Cells in Human Adult Lung from Studies of Transplanted Allografts. J Clin Invest 2007,117(4):989–996.CrossRefPubMedPubMedCentral
13.
Popova AP, Bozyk PD, Goldsmith AM, Linn MJ, Lei J, Bentley JK, Hershenson MB: Autocrine production of TGF-{beta}1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. Am J Physiol Lung Cell Mol Physiol 2010, 298:L735–743.CrossRefPubMedPubMedCentral
14.
Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F, Bou-Gharios G, Jeffery R, Iredale JP, Forbes SJ: The Bone Marrow Functionally Contributes to Liver Fibrosis. Gastroenterology 2006,130(6):1807–1821.CrossRefPubMed
15.
Jeon ES, Moon HJ, Lee MJ, Song HY, Kim YM, Cho M, Suh DS, Yoon MS, Chang CL, Jung JS, et al.: Cancer-Derived Lysophosphatidic Acid Stimulates Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells. Stem Cells 2008,26(3):789–797.CrossRefPubMed
16.
Sarugaser R, Hanoun L, Keating A, Stanford WL, Davies JE: Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic Hierarchy. PLoS One 2009,4(8):e6498.CrossRefPubMedPubMedCentral
17.
Ebina M, Takahashi T, Chiba T, Motomiya M: Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 1993,148(3):720–726.CrossRefPubMed
18.
Woodruff PG, Dolganov GM, Ferrando RE, Donnelly S, Hays SR, Solberg OD, Carter R, Wong HH, Cadbury PS, Fahy JV: Hyperplasia of Smooth Muscle in Mild to Moderate Asthma without Changes in Cell Size or Gene Expression. Am J Respir Crit Care Med 2004,169(9):1001–1006.CrossRefPubMed
19.
Roche WR, Williams JH, Beasley R, Holgate ST: Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520–524.CrossRefPubMed
20.
Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR: Myofibroblasts and subepithelial fibrosis in bronchial asthma. American Journal of Respiratory Cell & Molecular Biology 1990,3(5):507–511.CrossRef
21.
Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, laRocca AM, Bellia V, Bonsignore G, Bousquet J: Transforming growth factor-B expression in mucosa biopsies in asthma and chronic bronchitis. Am J Resp Crit Care Med 1997, 156:591–599.CrossRefPubMed
22.
Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK: Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 1997, 16:664–673.CrossRefPubMed
23.
Dolhnikoff M, da Silva LFF, de Araujo BB, Gomes HAP, Fernezlian S, Mulder A, Lindeman JH, Mauad T: The outer wall of small airways is a major site of remodeling in fatal asthma. Journal of Allergy and Clinical Immunology 2009,123(5):1090–1097. e1091CrossRefPubMed
24.
Larsen K, Tufvesson E, Malmstrom J, Morgelin M, Wildt M, Andersson A, Lindstrom A, Malmstrom A, Lofdahl CG, Marko-Varga G, et al.: Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma. Am J Respir Crit Care Med 2004, 170:1049–1056.CrossRefPubMed
25.
Xisto DG, Farias LL, Ferreira HC, Picanco MR, Amitrano D, Lapa e Silva JR, Negri EM, Mauad T, Carnielli D, Silva LFF, et al.: Lung Parenchyma Remodeling in a Murine Model of Chronic Allergic Inflammation. Am J Respir Crit Care Med 2005,171(8):829–837.CrossRefPubMed
26.
Henderson WR JR, Tang LO, Chu SJ, Tsao SM, Chiang GKS, Jones F, Jonas M, Pae C, Wang H, Chi EY: A Role for Cysteinyl Leukotrienes in Airway Remodeling in a Mouse Asthma Model. Am J Respir Crit Care Med 2002,165(1):108–116.CrossRefPubMed
27.
Leigh R, Ellis R, Wattie J, Southam DS, De Hoogh M, Gauldie J, O'Byrne PM, Inman MD: Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. American Journal Of Respiratory Cell And Molecular Biology 2002,27(5):526–535.CrossRefPubMed
28.
Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA: Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980, 56:289–301.PubMed
29.
Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289–300.
30.
Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ: Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 2005,320(2):269–276.CrossRefPubMed
31.
Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC: SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 2007,109(4):1743–1751.CrossRefPubMed
32.
McQualter JL, Brouard N, Williams B, Baird BN, Sims-Lucas S, Yuen K, Nilsson SK, Simmons PJ, Bertoncello I: Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the Sca-1 positive cell fraction. Stem Cells 2008. stemcells.2008–0866
33.
Dennis JE, Carbillet JP, Caplan AI, Charbord P: The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 2002, 170:73–82.CrossRefPubMed
34.
Blazsek I, Chagraoui J, Péault B: Ontogenic emergence of the hematon, a morphogenetic stromal unit that supports multipotential hematopoietic progenitors in mouse bone marrow. Blood 2000, 96:3763–3771.PubMed
35.
Kémoun P, Laurencin-Dalicieux S, Rue J, Vaysse F, Roméas A, Arzate H, Conte-Auriol F, Farges JC, Salles JP, Brunel G: Localization of STRO-1, BMP-2/-3/-7, BMP receptors and phosphorylated Smad-1 during the formation of mouse periodontium. Tissue Cell 2007, 39:257–266.CrossRefPubMed
36.
Delorme B, Ringe J, Gallay N, Le Vern Y, Kerboeuf D, Jorgensen C, Rosset P, Sensebé L, Layrolle P, Häupl T, et al.: Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 2008, 111:2631–2635.CrossRefPubMed
37.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006,8(4):315–317.CrossRefPubMed
38.
Bentley JK, Deng H, Linn MJ, Lei J, Dokshin GA, Fingar DC, Bitar KN, Henderson WR, Hershenson MB: Airway smooth muscle hyperplasia and hypertrophy correlate with glycogen synthase kinase-3{beta} phosphorylation in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol 2009, 296:L176–184.CrossRefPubMed
39.
Oh SP, Yeo CY, Lee Y, Schrewe H, Whitman M, Li E: Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. Genes & Development 2002,16(21):2749–2754.CrossRef
40.
Andersson O, Reissmann E, Ibanez CF: Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep 2006,7(8):831–837.PubMedPubMedCentral
41.
Michos O, Panman L, Vintersten K, Beier K, Zeller R, Zuniga Ae: Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 2004,131(14):3401–3410.CrossRefPubMed
42.
Ikeya M, Kawada M, Kiyonari H, Sasai N, Nakao K, Furuta Y, Sasai Y: Essential pro-Bmp roles of crossveinless 2 in mouse organogenesis. Development 2006,133(22):4463–4473.CrossRefPubMed
43.
Deng H, Dokshin GA, Lei J, Goldsmith AM, Bitar KN, Fingar DC, Hershenson MB, Bentley JK: Inhibition of Glycogen Synthase Kinase-3{beta} Is Sufficient for Airway Smooth Muscle Hypertrophy. J Biol Chem 2008,283(15):10198–10207.CrossRefPubMedPubMedCentral
44.
Berman JS, Serlin D, Li X, Whitley G, Hayes J, Rishikof DC, Ricupero DA, Liaw L, Goetschkes M, O'Regan AW: Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. Am J Physiol Lung Cell Mol Physiol 2004,286(6):L1311–1318.CrossRefPubMed
45.
Kohan M, Breuer R, Berkman N: Osteopontin Induces Airway Remodeling and Lung Fibroblast Activation in a Murine Model of Asthma. Am J Respir Cell Mol Biol 2009,41(3):290–296.CrossRefPubMed
46.
Jarvinen L, Badri L, Wettlaufer S, Ohtsuka T, Standiford TJ, Toews GB, Pinsky DJ, Peters-Golden M, Lama VN: Lung Resident Mesenchymal Stem Cells Isolated from Human Lung Allografts Inhibit T Cell Proliferation via a Soluble Mediator. J Immunol 2008,181(6):4389–4396.CrossRefPubMedPubMedCentral
47.
Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. PNAS 2003,100(14):8407–8411.CrossRefPubMedPubMedCentral
48.
Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman R, Brigham KL: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005, 33:145–152.CrossRefPubMedPubMedCentral
49.
Ortiz LA, DuTreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG: Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proceedings of the National Academy of Sciences 2007,104(26):11002–11007.CrossRef
50.
Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA: Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice. J Immunol 2007,179(3):1855–1863.CrossRefPubMed
51.
Nilsen-Hamilton MHR, Alvarez-Azaustre E: Relationship between mitogen-regulated protein (MRP) and proliferin (PLF), a member of the prolactin/growth hormone family. Gene 1987,51(2):163–170.CrossRefPubMed
52.
Wiemers DO, Shao Lj, Ain R, Dai G, Soares MJ: The Mouse Prolactin Gene Family Locus. Endocrinology 2003,144(1):313–325.CrossRefPubMed
53.
Fassett JT, Nilsen-Hamilton M: Mrp3, a Mitogen-Regulated Protein/Proliferin Gene Expressed in Wound Healing and in Hair Follicles. Endocrinology 2001,142(5):2129–2137.PubMed
54.
Corbacho A, Martinez De La Escalera G, Clapp C: Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. J Endocrinol 2002,173(2):219–238.CrossRefPubMed
55.
Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E: Prolactin alters the mechanisms of B cell tolerance induction. Arthritis & Rheumatism 2009,60(6):1743–1752.CrossRef
Metadata
Title
Ovalbumin sensitization and challenge increases the number of lung cells possessing a mesenchymal stromal cell phenotype
Authors
J Kelley Bentley
Antonia P Popova
Paul D Bozyk
Marisa J Linn
Amy E Baek
Jing Lei
Adam M Goldsmith
Marc B Hershenson
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2010
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-11-127

Other articles of this Issue 1/2010

Respiratory Research 1/2010 Go to the issue

Research

Mechanical ventilation modulates TLR4 and IRAK-3 in a non-infectious, ventilator-induced lung injury model

Review

New approaches in the diagnosis and treatment of latent tuberculosis infection

Research

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium

Research

Asthma and gender impact accumulation of T cell subtypes

Research

Variability in the precursor proteins of collagen I and III in different stages of COPD

Research

Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits